The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients

Conditions:   Systemic Lupus Erythematosus;   Arthritic Psoriasis;   Psoriasis;   Inflammatory Bowel Diseases Interventions:   Drug: BMS-986165;   Drug: Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 μg ethinyl estradiol) Sponsor:   Bristol-Myers Squibb Not yet recruiting - verified August 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials